Sonoma Pharmaceuticals (SNOA) Other Non Operating Income (2010 - 2020)
Sonoma Pharmaceuticals' (SNOA) quarterly Other Non Operating Income came in at $234000.0 in Q1 2020, up 73.33% year-on-year from $135000.0 in Q2 2019, and up 274.63% quarter-over-quarter from -$134000.0 in Q4 2019.
Sonoma Pharmaceuticals (SNOA) Other Non Operating Income (2010 - 2020) Analysis & Trends
Sonoma Pharmaceuticals' Other Non Operating Income history runs 11 years deep, the most recent figure standing at $234000.0 for Q1 2020.
- On a quarterly basis, Other Non Operating Income rose 73.33% year-over-year to $234000.0 in Q1 2020; TTM through Mar 2020 was $257000.0, a 25800.0% increase from a year earlier, with the FY2022 full-year figure at $723000.0, changed N/A from the prior year.
- Other Non Operating Income rose to $234000.0 in Q1 2020 per SNOA's latest filing, from -$134000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $234000.0 in Q1 2020 and bottomed at -$158000.0 in Q1 2017.
- The 5-year median for Other Non Operating Income is $3000.0 (2016), against an average of $13142.9.
- Across the five-year window, Other Non Operating Income soared 105.08% in 2016 and tumbled 1480.0% in 2017, its largest moves.
- Year by year, Other Non Operating Income stood at $3000.0 in 2016, then tumbled by 5366.67% to -$158000.0 in 2017, then soared by 113.92% to $22000.0 in 2018, then plunged by 709.09% to -$134000.0 in 2019, then surged by 274.63% to $234000.0 in 2020.
- Per Business Quant, the three latest SNOA Other Non Operating Income figures stand at $234000.0 (Q1 2020), -$134000.0 (Q4 2019), and $135000.0 (Q1 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 234,000.00 |
| Dec 31, 2019 | -134,000.00 |
| Mar 31, 2019 | 135,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Mar 31, 2017 | -158,000.00 |
| Jun 30, 2016 | 3,000.00 |
| Mar 31, 2016 | -10,000.00 |
| Dec 31, 2015 | 4,000.00 |
| Sep 30, 2015 | 65,000.00 |
| Jun 30, 2015 | -59,000.00 |
| Mar 31, 2015 | 166,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Sep 30, 2014 | -14,000.00 |
| Jun 30, 2014 | 1.48 Mn |
| Mar 31, 2013 | 1,000.00 |
| Dec 31, 2012 | -84,000.00 |
| Sep 30, 2012 | -397,000.00 |
| Jun 30, 2012 | 1.25 Mn |
| Mar 31, 2012 | -21,000.00 |
| Dec 31, 2011 | 86,000.00 |